Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$10.96
0.121.11%
Last update: Sep 10, 11:59 AM
Evommune Inc (EVMN) Stock Price, Quote, News & History
EVMNNYSE
PRO
Evommune (EVMN) Stock Price, Quote, News & History | Benzinga
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Evommune (EVMN) stock?
You can purchase shares of Evommune (NYSE:EVMN) through any online brokerage.
Who are Evommune (EVMN) competitors?
Other companies in Evommune’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
What is the forecast, or price target, for Evommune (EVMN) stock?
Evommune has a consensus price target of $34.00.
What is the current price for Evommune (EVMN)?
The stock price for Evommune (NYSE: EVMN) is $10.96 last updated September 10, 2026 at 11:59 AM EDT.
Does Evommune (EVMN) pay a dividend?
There are no upcoming dividends for Evommune.
When is Evommune (NYSE:EVMN) reporting earnings?
Evommune does not have any upcoming earnings scheduled.
Is Evommune (EVMN) going to split?
There is no upcoming split for Evommune.
What sector and industry does Evommune (EVMN) operate in?
Evommune is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.
